
Renal allograft nephropathy in patient with type 1 diabetes mellitus
Author(s) -
Е. В. Иванникова,
Olga K. Vikulova
Publication year - 2012
Publication title -
saharnyj diabet
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.155
H-Index - 12
eISSN - 2072-0378
pISSN - 2072-0351
DOI - 10.14341/2072-0351-5984
Subject(s) - medicine , allotransplantation , diabetes mellitus , diabetic nephropathy , nephropathy , chronic allograft nephropathy , type 2 diabetes mellitus , disease , renal replacement therapy , urology , type 1 diabetes , surgery , transplantation , endocrinology
Renal allotransplantation is the most effective and safest mode of renal replacement therapy in patients with diabetes mellitus (DM),and currently is recognized as method of choice for patients with end-stage renal disease. Due to variety of factors damaging transplantedkidney in patients with DM, issues of long-term survival of the graft constitute a serious problem. Therefore, special attentionshould be directed at correction of rejection risk factors in order to prolong graft survival - and prevent development and progressionof chronic allograft nephropathy.